.webp){kind=spacer}
Intestinal failure in neonatal and pediatric patients is associated with substantial morbidity and mortality, most commonly caused by necrotising enterocolitis1, affecting 1 in 1,000 premature babies2.
Current management includes the formation of double enterostomy and patients will often present with high-output stoma losses resulting in dehydration and malnutrition and may require ongoing parenteral nutrition support.
Historically, the mortality rate of necrotising enterocolitis (NEC) is as high as 50%3, making it one of the leading causes of death in preterm infants and is associated with life long morbidity and reduced quality of life4
The Insides Neo offers significant benefits compared to the current standard of care, including：
1. Nutritional & Fluid Benefits
2. Reduction in Surgical and Ostomy Complications
3. Clinical Workflow Benefits
Caution：Investigational device. Limited by United States law to investigational use.
.png){kind=small}
